{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T14:50:19Z","timestamp":1742914219888,"version":"3.40.3"},"publisher-location":"Cham","reference-count":27,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783319186177"},{"type":"electronic","value":"9783319186184"}],"license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1007\/978-3-319-18618-4_7","type":"book-chapter","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T10:20:49Z","timestamp":1442312449000},"page":"131-145","source":"Crossref","is-referenced-by-count":2,"title":["Requirements for Clinical Trials with Gene Therapy and Transplant Products in Switzerland"],"prefix":"10.1007","author":[{"given":"Andreas","family":"Marti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"7_CR1","unstructured":"Ordinance on Clinical Trials in Human Research. SR810.305. http:\/\/www.admin.ch\/opc\/en\/classified-compilation\/20121176\/index.html"},{"key":"7_CR2","unstructured":"Federal Act of 15 December 2000 on Medicinal Products and Medical Devices (Therapeutic Products Act, TPA). SR812.21. http:\/\/www.admin.ch\/ch\/e\/rs\/c812_21.html"},{"key":"7_CR3","unstructured":"Federal Act of 8 October 2004 on the Transplantation of Organs, Tissues and Cells (Transplantation Act). SR810.21. http:\/\/www.admin.ch\/ch\/e\/rs\/c810_21.html"},{"key":"7_CR4","unstructured":"Federal Act of 30 September 2011 on Research involving Human Beings (Human Research Act, HRA). SR810.30. http:\/\/www.admin.ch\/ch\/e\/rs\/c810_30.html"},{"key":"7_CR5","unstructured":"Federal Act on Non-Human Gene Technology. SR814.91. http:\/\/www.admin.ch\/opc\/en\/classified-compilation\/19996136\/index.html"},{"key":"7_CR6","unstructured":"ICH Harmonised Tripartite Guideline. Guideline For Good Clinical Practice E6(R1). http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E6\/E6_R1_Guideline.pdf"},{"key":"7_CR7","unstructured":"http:\/\/www.picscheme.org\/publication.php?id=4"},{"key":"7_CR8","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nature03556","volume":"435","author":"FD Urnov","year":"2005","unstructured":"Urnov FD, Miller JC et al (2005) Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 435:646\u2013651","journal-title":"Nature"},{"key":"7_CR9","doi-asserted-by":"crossref","unstructured":"Doudna J, Charpentier E (2014) The new frontier of genome engineering with CRISPR-Cas9. Science 346:1258096-1\u20131258096-9","DOI":"10.1126\/science.1258096"},{"key":"7_CR10","unstructured":"Federal Constitution of the Swiss Confederation of April 18, 1999. http:\/\/www.admin.ch\/org\/polit\/00083\/index.html?lang=en"},{"key":"7_CR11","unstructured":"Regulation (EC) No 1394\/2007 of the European Parliament and of the council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001\/83\/EC and Regulation (EC) No 726\/2004. http:\/\/ec.europa.eu\/health\/files\/eudralex\/vol-1\/reg_2007_1394\/reg_2007_1394_en.pdf"},{"key":"7_CR12","unstructured":"Requirements relating to the authorization documentation for transplant products (TP). Information sheet. https:\/\/www.swissmedic.ch\/bewilligungen\/00155\/00242\/00243\/00245\/00246\/00247\/01905\/01906\/index.html?lang=en"},{"key":"7_CR13","unstructured":"U.S. Food and Drug Administration. Cellular & gene therapy guidances. http:\/\/www.fda.gov\/BiologicsBloodVaccines\/GuidanceComplianceRegulatoryInformation\/Guidances\/CellularandGeneTherapy\/"},{"key":"7_CR14","unstructured":"European Medicines Agency. Advanced therapies scientific guidelines. http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/regulation\/general\/general_content_000298.jsp&mid=WC0b01ac05800862bd"},{"key":"7_CR15","unstructured":"Anforderungen an die einzureichenden Unterlagen bei einem klinischen Versuch mit Transplantatprodukten (TpP), Gentherapie (GT) oder GVO. Merkblatt. https:\/\/www.swissmedic.ch\/bewilligungen\/00155\/00242\/00328\/index.html?lang=en"},{"key":"7_CR16","unstructured":"ICH Harmonised Tripartite Guideline. Guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals M3(R2). http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Multidisciplinary\/M3_R2\/Step4\/M3_R2__Guideline.pdf"},{"key":"7_CR17","unstructured":"European Medicines Agency. Guideline on the non-clinical studies required before first clinical use of gene therapy medicinal products. EMEA\/CHMP\/GTWP\/125459\/2006. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500003743.pdf"},{"key":"7_CR18","unstructured":"Guidance for industry. Preclinical assessment of investigational cellular and gene therapy products. http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/GuidanceComplianceRegulatoryInformation\/Guidances\/CellularandGeneTherapy\/UCM376521.pdf"},{"key":"7_CR19","unstructured":"ICH Considerations (2006) General principles to address the risk of inadvertent germline integration of gene therapy vectors. http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Consideration_documents\/GTDG_Considerations_Documents\/ICH_Considerations_General_Principles_Risk_of_IGI_GT_Vectors.pdf"},{"key":"7_CR20","unstructured":"ICH Considerations (2009) General principles to address virus and vector shedding. http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Consideration_documents\/GTDG_Considerations_Documents\/ICH_Considerations_Viral-Vector_Shedding_.pdf"},{"key":"7_CR21","unstructured":"Instructions for the compilation of the documentation on possible risks for humans and the environment in support of applications for the authorisation to carry out clinical trials of somatic gene therapy and with medicines containing genetically modified microorganisms (environmental data). https:\/\/www.swissmedic.ch\/bewilligungen\/00155\/00242\/00328\/index.html?lang=en"},{"key":"7_CR22","unstructured":"Ordinance of 18 May 2005 on good laboratory practice (OGLP). SR813.112.1. http:\/\/www.admin.ch\/ch\/e\/rs\/8\/813.112.1.en.pdf"},{"key":"7_CR23","unstructured":"Mandatory reporting of adverse reactions during a clinical Trial with TrP\/GT\/GMO. Information sheet. https:\/\/www.swissmedic.ch\/bewilligungen\/00155\/00242\/00328\/index.html?lang=en"},{"key":"7_CR24","unstructured":"Verordnung \u00fcber die Transplantation von menschlichen Organen, Geweben und Zellen (Transplantationsverordnung). https:\/\/www.swissmedic.ch\/zulassungen\/00153\/00205\/00212\/index.html?lang=en"},{"key":"7_CR25","unstructured":"ICH Harmonised Tripartite Guideline. Derivation and characterization of cell substrates used for production of biotechnological\/biological products Q5D. http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Quality\/Q5D\/Step4\/Q5D_Guideline.pdf"},{"key":"7_CR26","unstructured":"Transplantatprodukte (TpP) Stoffe tiereischer und humanen Ursprungs. https:\/\/www.swissmedic.ch\/bewilligungen\/00155\/00242\/00243\/00245\/00246\/00247\/01905\/index.html?lang=en"},{"key":"7_CR27","unstructured":"ICH Harmonised Tripartite Guideline. ICH common technical document for the registration of pharmaceuticals for human use M4. http:\/\/www.ich.org\/products\/ctd.html"}],"container-title":["Advances in Experimental Medicine and Biology","Regulatory Aspects of Gene Therapy and Cell Therapy Products"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-18618-4_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T13:05:21Z","timestamp":1674911121000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-319-18618-4_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"ISBN":["9783319186177","9783319186184"],"references-count":27,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-18618-4_7","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2015]]}}}